Overview

The translation of bench research into the clinical environment has accelerated significantly in recent years, and the need for clinically validated workflows has never been stronger. This webinar takes a closer look at this need, particularly in the oncology space, and discusses what the future for workflow validation might be. The considerable knowledge built up over years—and especially during the recent COVID-19 pandemic—is relevant to many disease states and can be applied universally, ensuring that globally standardized, scalable technologies can realize their full clinical potential.

The discussion will include:

• The latest developments in integrated diagnostics and patient profiling, combining molecular and proteomics workflows
• The urgent need for translational research of biomarkers that have clinical relevance for optimizing diagnosis and treatment plans
• The challenges of translating new techniques—such as liquid biopsies—into regulated, scalable methodologies that will drive future global diagnostics and therapeutics
• The importance of building firm foundations in robust and reproducible research technologies, democratization of automated workflows, and digital connectivity of data.

Speaker: Achim von Leoprechting, Ph.D.

Tecan
Männedorf, Switzerland

Speaker: Stephen Harding, Ph.D.

The Binding Site
Birmingham, UK

Moderator: Sean Sanders, Ph.D.

Science/AAAS
Washington, DC

For more information and to register for this free webinar, go here.

This webinar will take place on Wednesday, December 8, 2021 at 12:00pm Eastern (9 a.m. Pacific, 5 p.m. UK (GMT), 6 p.m. Central Europe (CET))